Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/2906
Title: Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells
Authors: Newbold, RF
Dafou, D
Ramus, SJ
Choi, K
Grun, B
Trott, DA
Jacobs, IJ
Jones, CS
Gayther, SA
Keywords: Chromosome 16;Chromosome 18;Induce neoplastic suppression;Ovarian cancer cells
Issue Date: 2008
Publisher: Wiley
Citation: International Journal of Cancer 124(5): 1037-1044, Mar 2009
Abstract: Metaphase comparative genomic hybridisation (CGH) studies indicate that chromosomes 4, 5, 6, 13, 14, 15, and 18 are frequently deleted in primary ovarian cancers (OC). Therefore we used microcell-mediated chromosome transfer (MMCT) to establish the functional effects of transferring normal copies of these chromosomes into two epithelial OC cell lines (TOV112D and TOV21G). The in vitro neoplastic phenotype (measured as anchorage dependent and independent growth and invasion) was compared between recipient OC cell lines and multiple MMCT hybrids. Chromosomes 6 and 18 showed strong evidence of functional, neoplastic suppression for multiple hybrids in both cell lines. We also found evidence in one cancer cell line suggesting that chromosomes 4, 13 and 14 may also cause functional suppression. Array CGH and microsatellite analyses were used to characterise the extent of genomic transfer in chromosome 6 and 18 hybrids. A 36Mb deletion on chromosome 6 in two hybrids from one cell line mapped the candidate region proximal to 6q15 and distal to 6q22.2; and an approximately 10Mb candidate region spanning the centromere on chromosome 18, was identified in two hybrids from the other cell line. These data confirm reported functional effects of chromosome 6 in OC cell lines; but to our knowledge, this is the first time that functional suppression for chromosome 18 has been reported. This suggests that these chromosomes may harbour tumour suppressor like genes. The future identification of these genes may have a significant impact on the understanding and treatment of the disease, the identification of novel therapeutic targets.
URI: http://bura.brunel.ac.uk/handle/2438/2906
http://www.ncbi.nlm.nih.gov/pubmed/19058220
DOI: http://dx.doi.org/10.1002/ijc.24058
Appears in Collections:Biological Sciences
Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Closed Access Paper.txt282 BTextView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.